Heart News and Research

RSS

Bench to Bassinet Program aims to move lab results into clinical practice

To help speed the translation of scientific discoveries into usable treatments in congenital heart disease, the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health launched the Bench to Bassinet Program.

17 Mar 2010

New heart-healthy omega-3 crops on horizon

A new heart-healthy, essential omega-3 fatty acid is about to improve an American pantry staple: soybean oil. The new scientific advance will move biotechnology onto the average consumer's daily radar.

17 Mar 2010

Boston University's Technology Development Office completes exclusive license of Project RED to Engineered Care

Boston University's Technology Development Office, on behalf of Boston Medical Center, Northeastern University, and Massachusetts Institute of Technology (MIT), has completed the exclusive license of Project RED (Re-Engineered Discharge) to Engineered Care, Inc.

17 Mar 2010

Anti-obesity drugs fail to tackle wider issues of obesity

Scientists at the University of Liverpool argue that anti-obesity drugs fail to provide lasting benefits for health and wellbeing because they tackle the biological consequences of obesity, and not the important psychological causes of overconsumption and weight gain.

17 Mar 2010

Study suggests doctors overlook effects of implanted heart defibrillators in dying patients

The Associated Press reports that heart defibrillators implanted in a patient's chest may disrupt a quiet death, but doctors and relatives of people dying of non-heart related diseases often don't consider that issue. "It's not unusual for health professionals to avoid the topic, says Dr. Nathan Goldstein of New York's Mount Sinai Medical Center.

17 Mar 2010

Obese patients face lower risk of sudden cardiac death compared to non-obese patients

Obesity has long been identified as a risk factor for cardiovascular disease and heart failure. But, a new study conducted by researchers at the University of Rochester Medical Center found that being skinny confers no advantage when it comes to the risk of dying suddenly from cardiac causes.

17 Mar 2010

Glenmark Generics, Konec ordered to stop marketing unapproved nitroglycerin tablets

The U.S. Food and Drug Administration today ordered Glenmark Generics of Mahwah, N.J., and Konec Inc. of Tucson, Ariz., to stop marketing unapproved nitroglycerin tablets. The tablets are placed under the tongue to relieve chest pain or to stop a heart attack and are marketed in 0.3 mg, 0.4 mg, and 0.6 mg dosages.

17 Mar 2010

Heart disease patients may benefit from secondary preventive care

Research has shown that heart disease patients who make lifestyle improvements, take recommended medications and control risk factors such as high cholesterol and high blood pressure can prevent heart disease from worsening.

17 Mar 2010

Women on oral contraceptive pills live longer

Women who are taking or have taken the contraceptive pill in their lifetimes are not at an increased risk of death, Scottish researchers say. In fact, the pill may help to prolong life.

17 Mar 2010

Medtronic launches Every Patient First health equity initiative.

Medtronic, Inc. today introduced Every Patient First, a health equity initiative that, in partnership with health care providers, professional societies and patient advocacy groups, aims to reduce disparities in access to health care in the United States. The announcement was made at the 59th Annual Scientific Session of the American College of Cardiology in Atlanta.

17 Mar 2010

Unapproved nitroglycerin tablets: FDA orders Glenmark Generics and Konec to stop marketing

17 Mar 2010

Human amniotic fluid skin cells "reprogrammed" to pluripotency

In a breakthrough that may help fill a critical need in stem cell research and patient care, researchers at Mount Sinai School of Medicine have demonstrated that skin cells found in human amniotic fluid can be efficiently "reprogrammed" to pluripotency, where they have characteristics similar to human embryonic stem cells that can develop into almost any type of cell in the human body. The study is online now and will appear in print in the next issue of the journal Cellular Reprogramming, to be published next month.

16 Mar 2010

Mortality in CAD patients: Key predictor identified

Coronary Artery Disease (CAD) hospitalizes more than 160,000 Canadians every year, and almost one quarter of those patients die from this common form of heart disease. But now a team of Vancouver-based researchers has identified a key predictor of mortality in CAD patients, which means that specialists can better determine how to treat and improve outcomes for patients with CAD.

16 Mar 2010

'Molecular band-aid' may help protect hearts of Duchenne muscular dystrophy patients

Researchers at the University of Minnesota Medical School have discovered a chemical that may, over the long term, protect the hearts of Duchenne muscular dystrophy patients - a fatal and most common form of muscular dystrophy in children.

16 Mar 2010

Angioplasty: Complexity of heart disease, gender and body size influence cumulative radiation skin dose

Body size, gender and the complexity of heart disease significantly influence how much cumulative radiation skin dose that patients receive during percutaneous coronary intervention (PCI) therapy, also known as angioplasty, according to a new Mayo Clinic study. The study was undertaken as a quality control initiative to reduce the potential radiation risks of cancer to patients and PCI operators.

16 Mar 2010

Toshiba displays new, advanced ultrasound systems at ACC annual meeting

Health care facilities use ultrasound as a first-line diagnostic exam to quickly and efficiently perform a range of patient exams, including cardiac imaging. Developed to meet these demanding clinical needs, Toshiba America Medical Systems, Inc. will showcase the advanced cardiac capabilities of its AplioTM MX and Aplio ArtidaTM ultrasound systems at this year’s American College of Cardiology (ACC) annual meeting in Atlanta, March 14-16, 2010 (Booth #1944). This is the first appearance of the Aplio MX at ACC.

16 Mar 2010

Hybrid revascularization procedure is safe and feasible for left main coronary artery stenosis

The left main coronary artery provides most of the blood to the heart, and current guidelines call for patients with blockages in this artery to undergo bypass surgery.

16 Mar 2010

Lipitor 80 mg may help reduce risk of major cardiovascular events in high-risk patients

Lipitor® (atorvastatin calcium) 80 mg was associated with a significantly reduced risk of major cardiovascular events compared with Lipitor 10 mg among patients with both coronary heart disease (CHD) and chronic kidney disease (CKD) who were obese or had metabolic syndrome. These data, from two sub-analyses of the Treating to New Targets (TNT) trial that were designed and completed following the completion of TNT, were presented today at the 59th Annual Scientific Session of the American College of Cardiology (ACC) in Atlanta, Ga.

16 Mar 2010

PERSEUS clinical program demonstrates positive results of TAXUS Element Paclitaxel-Eluting Stent System

Boston Scientific Corporation today announced 12-month results from its PERSEUS clinical program that demonstrated positive safety and efficacy outcomes in workhorse lesions for the platinum chromium TAXUS® Element™ Paclitaxel-Eluting Stent System compared to the TAXUS® Express2™ Paclitaxel-Eluting Stent System.

16 Mar 2010

Study suggests HuR gene plays a critical role in inducing cells' inflammatory response

To understand the role of inflammation in cardiovascular and other diseases, it is essential to identify and characterize genes that induce an inflammatory response in the body -- and the genes that regulate them.

16 Mar 2010

Heart News and Research

Bench to Bassinet Program aims to move lab results into clinical practice

New heart-healthy omega-3 crops on horizon

Boston University's Technology Development Office completes exclusive license of Project RED to Engineered Care

Anti-obesity drugs fail to tackle wider issues of obesity

Study suggests doctors overlook effects of implanted heart defibrillators in dying patients

Obese patients face lower risk of sudden cardiac death compared to non-obese patients

Glenmark Generics, Konec ordered to stop marketing unapproved nitroglycerin tablets

Heart disease patients may benefit from secondary preventive care

Women on oral contraceptive pills live longer

Medtronic launches Every Patient First health equity initiative.

Unapproved nitroglycerin tablets: FDA orders Glenmark Generics and Konec to stop marketing

Human amniotic fluid skin cells "reprogrammed" to pluripotency

Mortality in CAD patients: Key predictor identified

'Molecular band-aid' may help protect hearts of Duchenne muscular dystrophy patients

Angioplasty: Complexity of heart disease, gender and body size influence cumulative radiation skin dose

Toshiba displays new, advanced ultrasound systems at ACC annual meeting

Hybrid revascularization procedure is safe and feasible for left main coronary artery stenosis

Lipitor 80 mg may help reduce risk of major cardiovascular events in high-risk patients

PERSEUS clinical program demonstrates positive results of TAXUS Element Paclitaxel-Eluting Stent System

Study suggests HuR gene plays a critical role in inducing cells' inflammatory response

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News